日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Optimizing the thermostability of triketone dioxygenase for engineering tolerance to mesotrione herbicide in soybean and cotton.

优化三酮双加氧酶的热稳定性,以增强大豆和棉花对甲磺草酮除草剂的耐受性

Duff Stephen M G, Shi Lei, Chen Danqi, Fu Xiaoran, Peng Mingsheng, Larue Clayton T, Weihe Janice, Koczan Jessica, Krebel Brian, Qi Qungang

Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis

厄贝沙坦通过抑制 Hippo/YAP1/c-Jun 轴来抑制干细胞和铁代谢,从而克服胰腺癌对吉西他滨的耐药性

Tianxing Zhou #, Yongjie Xie #, Xupeng Hou #, Weiwei Bai, Xueyang Li, Ziyun Liu, Quan Man, Jingyan Sun, Danqi Fu, Jingrui Yan, Zhaoyu Zhang, Yifei Wang, Hongwei Wang, Wenna Jiang, Song Gao, Tiansuo Zhao, Antao Chang, Xiuchao Wang, Hongxia Sun, Xiufeng Zhang, Shengyu Yang, Chongbiao Huang, Jihui Hao,

Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma

核 PLD1 与 NPM1 结合通过致瘤 IL7R 诱导胰腺腺癌产生吉西他滨耐药性

Danqi Fu #, Jingrui Yan #, Zhaoyu Zhang #, Yang Liu, Xiaoqing Ma, Jinsheng Ding, Shengyu Yang, Ran Zhao, Antao Chang, Chuntao Gao, Jing Liu, Tiansuo Zhao, Xiuchao Wang, Chongbiao Huang, Song Gao, Ying Ma, Bo Tang, Yukuan Feng, Hongwei Wang, Jihui Hao

Integrated single-cell multiomics analysis reveals novel candidate markers for prognosis in human pancreatic ductal adenocarcinoma

综合单细胞多组学分析揭示人类胰腺导管腺癌预后的新型候选标记

Xiaoying Fan #, Ping Lu #, Hongwei Wang #, Shuhui Bian #, Xinglong Wu #, Yu Zhang, Yang Liu, Danqi Fu, Lu Wen, Jihui Hao, Fuchou Tang

Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma

肿瘤内皮生长因子(EHF)可预测抗PD-1疗法在胰腺导管腺癌中的疗效

Jing Liu ,Wenna Jiang ,Kaili Zhao ,Hongwei Wang ,Tianxing Zhou ,Weiwei Bai ,Xiuchao Wang ,Tiansuo Zhao ,Chongbiao Huang ,Song Gao ,Tai Qin ,Wenwen Yu ,Bo Yang ,Xin Li ,Danqi Fu ,Wei Tan ,Shengyu Yang ,He Ren ,Jihui Hao